CIR Vaccine Trials – Currently Enrolling

The purpose of this study is to learn about the clinical presentation and duration of shedding of the Zika virus in healthy adults.  The study is:

• 6 months long
• enrolling FEMALES ONLY 18-40 years old
• includes 2-3 screening visits, one 16 day inpatient stay and 11 outpatient follow up visits
• pays up to $5025 for completion of all study procedures

Complete the CIR Contact Form

More about  Zika Virus

The purpose of this study is to evaluate the cross-species protection conferred by a re-challenge with a Shigella species of a different serotype.  The study (is):

• enrolling 18-50 year olds
• includes 1 or 2 ten day inpatient stays* (about 3-4 months apart)
• 4-5 outpatient visits after each inpatient stay
• Pays $3000 for one admission
• Pays $5750 for two admissions

*not all subjects will be selected to return for admission 2

Complete the CIR Contact Form

The purpose of this study is to evaluate the safety of receiving  a COVID-19 and Flu vaccine simultaneously versus receiving them 2 weeks apart.  The study is:

• 4 months long
• 1 phone screen
• 3 vaccination day visits
• 2 in person follow up visits
• 4 phone follow up visits

Complete the CIR Contact Form

The purpose of this study is to compare the safety of administering Shingrix (shingles vaccine) at the same time as FLUAD™ or Fluzone® High-Dose influenza vaccines in older people (all currently licensed vaccines).  The study is:

• 3.5 months long
• 1 phone screen
• 2 vaccination day visits
• 2 in-person follow-up visits
• 5 follow-up phone calls

Complete the CIR Contact Form

The purpose of this study is to evaluate the safety and efficacy of repeated oral doses to protect against exposure to dengue virus.  The study (is):

• 3 months long
• 2-3 screening visits
• 29 consecutive daily visits for oral dosing of medication
• 2 two-night inpatient stays
• 1 Dengue challenge visit
• 8 follow up visits
• pays up to $4910 for completion of all study procedures

Complete the CIR Contact Form

More about Dengue Virus

The purpose of this study is to demonstrate that a new (investigational) yellow fever vaccine is as safe and protective against yellow fever infection as the currently licensed yellow fever vaccine.  The study (is):

• enrolling 18-60 year olds
• includes 1 vaccination day visit
• includes 9-10 follow up visits over 5 years
• Pays $870-950 depending on visits completed

Complete the CIR Contact Form